North Star Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

North Star Investment Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.37K	Sell	7 -4	-36%	-$2.72K	﹤0.01%	1262
2026 Q1	$8.5K	Buy	11 +1	+10%	+$766	﹤0.01%	1068
2025 Q4	$7.72K	Buy	+10	New	+$6.79K	﹤0.01%	1008
2024 Q2	–	Sell	-2	Closed	-$1.93K	–	1222
2024 Q1	$1.93K	Hold	2	–	–	﹤0.01%	1093
2023 Q4	$1.76K	Hold	2	–	–	﹤0.01%	1057
2023 Q3	$1.65K	Hold	2	–	–	﹤0.01%	1080
2023 Q2	$1.44K	Hold	2	–	–	﹤0.01%	1105
2023 Q1	$1.64K	Hold	2	–	–	﹤0.01%	1105
2022 Q4	$1.44K	Buy	+2	New	+$1.48K	﹤0.01%	1122
2019 Q4	–	Sell	-3	Closed	-$1K	–	1086
2019 Q3	$1K	Buy	+3	New	+$888	﹤0.01%	1065

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

North Star Investment Management's REGN Position: Q2 2026 in Review

North Star Investment Management reduced its Regeneron Pharmaceuticals (REGN) stake by 36% in Q2 2026, selling an estimated $2.72K and leaving 7 shares worth $4.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1262.

North Star Investment Management first reported a position in REGN in Q3 2019 and has held it in 10 quarters since. The position peaked at $8.5K in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

North Star Investment Management held 7 shares of Regeneron Pharmaceuticals worth $4.37K as of Q2 2026.
North Star Investment Management sold 4 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.72K.
Regeneron Pharmaceuticals made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1262 holding.
North Star Investment Management first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 10 quarters since.
North Star Investment Management's Regeneron Pharmaceuticals position peaked at $8.5K in Q1 2026.
1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.